Roth Capital Downgrades Somaxon Pharma (SOMX) to Neutral
Tweet
Share
E-mailGet Alerts SOMX Hot Sheet
Price: $3.00 --0%
Rating Summary:
1 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
1 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Roth Capital downgraded Somaxon Pharma (NASDAQ: SOMX) from Buy to Neutral, price target lowered from $3 to $0.75.
For an analyst ratings summary and ratings history on Somaxon Pharma click here. For more ratings news on Somaxon Pharma click here.
Shares of Somaxon Pharma closed at $0.58 yesterday.
For an analyst ratings summary and ratings history on Somaxon Pharma click here. For more ratings news on Somaxon Pharma click here.
Shares of Somaxon Pharma closed at $0.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
- UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
- JPMorgan Downgrades Kuaishou Technology (1024:HK) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
